Olstykke, Denmark

Kasper Møller

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Firmenich Sa. Active years: 2011.



Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Kasper Møller in Terpene Production

Introduction

Kasper Møller is an innovative inventor based in Olstykke, Denmark. He has made significant contributions to the field of biotechnology, particularly in the production of terpenes through advanced microbial methods. His work has the potential to impact various industries, including pharmaceuticals and cosmetics.

Latest Patents

Kasper Møller holds a patent titled "Method for producing terpenes and MEP-transformed microorganisms therefore." This invention relates to a microorganism capable of producing a terpene of choice. The microorganism expresses a heterologous pathway for the formation of isoprene units and, preferably, a heterologous terpene synthase. In this way, high amounts of terpene can be isolated from the medium of the microorganism. He has 1 patent to his name.

Career Highlights

Kasper Møller is currently employed at Firmenich SA, a leading company in the field of fragrance and flavor creation. His role involves leveraging his expertise in microbial biotechnology to enhance the production processes of various compounds.

Collaborations

Kasper has collaborated with notable colleagues, including Jens Bredal Nielsen and Anthony Clark. Their combined efforts contribute to the advancement of innovative solutions in the field of terpene production.

Conclusion

Kasper Møller's work exemplifies the intersection of biotechnology and innovation, showcasing how microbial processes can be harnessed for the efficient production of valuable compounds. His contributions are paving the way for future advancements in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…